Ventas, Inc. $VTR Shares Sold by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio lessened its position in Ventas, Inc. (NYSE:VTR) by 13.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 676,228 shares of the real estate investment trust’s stock after selling 108,739 shares during the period. Public Employees Retirement System of Ohio’s holdings in Ventas were worth $55,302,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the company. NewEdge Advisors LLC boosted its position in Ventas by 856.1% during the first quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after acquiring an additional 7,097 shares during the last quarter. Empowered Funds LLC raised its holdings in Ventas by 6.8% in the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after acquiring an additional 536 shares during the last quarter. Woodline Partners LP raised its holdings in Ventas by 46.8% in the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after acquiring an additional 11,739 shares during the last quarter. Focus Partners Wealth lifted its stake in shares of Ventas by 130.4% during the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock worth $1,486,000 after purchasing an additional 12,233 shares during the period. Finally, Gamco Investors INC. ET AL purchased a new position in shares of Ventas during the 2nd quarter worth $805,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Insider Buying and Selling

In other Ventas news, Director Michael J. Embler purchased 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were purchased at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the acquisition, the director owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This represents a 14.97% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Walter C. Rakowich sold 1,152 shares of the firm’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the transaction, the director owned 28,349 shares in the company, valued at $2,557,079.80. The trade was a 3.90% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. Citigroup lifted their price objective on Ventas from $96.00 to $100.00 and gave the company a “buy” rating in a research report on Friday, May 1st. Evercore reissued an “outperform” rating and issued a $95.00 price target on shares of Ventas in a research note on Wednesday, April 29th. UBS Group lifted their price target on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a report on Monday, May 4th. KeyCorp upped their price objective on shares of Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. Fifteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $96.50.

Ventas Trading Up 0.8%

Shares of VTR opened at $97.97 on Friday. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $47.63 billion, a P/E ratio of 178.13, a price-to-earnings-growth ratio of 2.09 and a beta of 0.70. The stock’s fifty day simple moving average is $87.91 and its 200 day simple moving average is $84.74. Ventas, Inc. has a twelve month low of $65.15 and a twelve month high of $98.84.

Ventas (NYSE:VTR) last posted its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. Ventas’s revenue was up 22.0% on a year-over-year basis. During the same period last year, the firm posted $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, equities research analysts forecast that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th were issued a dividend of $0.52 per share. The ex-dividend date was Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.1%. Ventas’s payout ratio is presently 378.18%.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.